Sunnybrook Health Sciences Centre, one of Canada's largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year. The center is equipped with 13 linear accelerators. This is the first sale made in Ontario since a Master Purchase Agreement was signed with Ontario Health in the first quarter of 2022.
The agreement includes a complete configuration of RayStation to fully replace the hospital's existing treatment planning systems. The total order value is approximately CAD 6.2 million (approximately SEK 51.1 million), whereof at least CAD 3.5 million (SEK 28.8 million) is expected to constitute revenue in the third quarter of 2022. This excludes post-warranty support services which will amount to an additional CAD 1.88 million (approximately SEK 15.4 million) over the next eight years. A 36-month warranty is included in the order.
Johan Löf, founder and CEO, RaySearch, says: "Canada has one of the world's most advanced cancer care programs. RaySearch has many strong relationships with Canadian centers, both clinical and academic, and we are proud to see that also Sunnybrook has put their trust in us and our innovative software. We look forward to working with this large and well-known center to further advance cancer treatment."
This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 08:00 CET on September 7, 2022.